TY  - GEN
AU  - Henry,K
AU  - Wallace,R J
AU  - Bellman,P C
AU  - Norris,D
AU  - Fisher,R L
AU  - Ross,L L
AU  - Liao,Q
AU  - Shaefer,M S
TI  - Twice-daily triple nucleoside intensification treatment with lamivudine-zidovudine plus abacavir sustains suppression of human immunodeficiency virus type 1: results of the TARGET Study
SN  - 0022-1899
PY  - 2001///0322
KW  - Adult
KW  - Aged
KW  - Anti-HIV Agents
KW  - administration & dosage
KW  - CD4 Lymphocyte Count
KW  - Dideoxynucleosides
KW  - Drug Therapy, Combination
KW  - Female
KW  - HIV Infections
KW  - drug therapy
KW  - HIV-1
KW  - genetics
KW  - Humans
KW  - Lamivudine
KW  - Male
KW  - Middle Aged
KW  - RNA, Viral
KW  - blood
KW  - Reverse Transcriptase Inhibitors
KW  - therapeutic use
KW  - Treatment Outcome
KW  - Viral Load
KW  - Zidovudine
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study
UR  - https://doi.org/10.1086/318527
ER  -